|
TAF5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.56659999919862E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.52959999800385E-09 |
| Normal-vs-Stage2 |
7.904800E-03 |
| Normal-vs-Stage3 |
1.342840E-03 |
| Normal-vs-Stage4 |
3.76979999999749E-05 |
| Stage1-vs-Stage2 |
8.047400E-01 |
| Stage1-vs-Stage3 |
1.956060E-02 |
| Stage1-vs-Stage4 |
5.610800E-01 |
| Stage2-vs-Stage3 |
3.562600E-01 |
| Stage2-vs-Stage4 |
9.107000E-01 |
| Stage3-vs-Stage4 |
1.845610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.94859999539332E-08 |
| Normal-vs-AfricanAmerican |
3.395500E-04 |
| Normal-vs-Asian |
6.632200E-02 |
| Caucasian-vs-AfricanAmerican |
8.160000E-01 |
| Caucasian-vs-Asian |
3.287600E-01 |
| AfricanAmerican-vs-Asian |
3.743600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.24229999965264E-07 |
| Normal-vs-Female |
5.77819999625362E-08 |
| Male-vs-Female |
2.544800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.548290E-02 |
| Normal-vs-Age(41-60Yrs) |
2.12980000302565E-08 |
| Normal-vs-Age(61-80Yrs) |
1.0862999999528E-06 |
| Normal-vs-Age(81-100Yrs) |
6.177600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.068400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.333200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.141800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.958600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.633900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.621900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.838360E-04 |
| Normal-vs-Grade 2 |
2.73259970207107E-10 |
| Normal-vs-Grade 3 |
5.632400E-04 |
| Normal-vs-Grade 4 |
2.739700E-03 |
| Grade 1-vs-Grade 2 |
2.900400E-02 |
| Grade 1-vs-Grade 3 |
1.77476999999593E-05 |
| Grade 1-vs-Grade 4 |
4.565000E-04 |
| Grade 2-vs-Grade 3 |
1.391510E-04 |
| Grade 2-vs-Grade 4 |
1.700330E-02 |
| Grade 3-vs-Grade 4 |
6.438200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62719837604186E-11 |
| Normal-vs-ccB subtype |
1.077720E-02 |
| ccA subtype-vs-ccB subtype |
2.58350000004182E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08729999995327E-06 |
| Normal-vs-N1 |
3.339600E-02 |
| N0-vs-N1 |
7.907400E-01 |
|
|
